Ponezumab
Ponezumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Ponezumab is under investigation in clinical trial NCT00607308 (A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease).
| Trade Name | Ponezumab |
| Generic | Ponezumab |
| Ponezumab Other Names | PF-04360365, Ponezumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Ponezumab
